Search
for

    Learn

    5 / 801 results

      learn Bicalutamide

      a nonsteroidal anti-androgen, most commonly used orally for women

      learn Fluridil

      a topical anti-androgen with less systemic involvement

      learn RU58841

      a potent but unapproved and potentially problematic topical anti-androgen

      learn Cetirizine

      popular antihistamine showing promise for hair loss as an anti-inflammatory and prostaglandin inhibitor

    Research

    5 / 1000+ results

    Community Join

    5 / 1000+ results

      community Clascoterone/ Breezula will it work

      in Research/Science 1 week ago
      Breezula's effectiveness is uncertain, with some users skeptical about its potential and others noting its recent availability on the grey market. A user reported success with a stack of Dutasteride (oral), Minoxidil (topical), and RU58841 (topical), achieving significant hair improvement after 18 months.

      community Pyrludimide (KX-826) or Breezula (clascoterone)

      in Treatment  9 upvotes 3 weeks ago
      The conversation is about hair loss treatments, specifically Pyrludimide (KX-826) and Breezula (clascoterone), with the user unable to tolerate finasteride and dutasteride. The user plans to use these treatments alongside minoxidil, considering the efficacy and availability of each option.

      community CB-03-01 / Breezula Personal Results

      in Treatment  16 upvotes 2 months ago
      The user shared their experience with CB-03-01 (Breezula/Clascoterone) for hair loss, noting reduced shedding and improved hair appearance but experiencing significant sleep disturbances and low energy due to HPA axis suppression. They decided to stop using it due to these side effects and are waiting for GT20029 as an alternative.

      community Breezula 6 Month Topline Phase III Results Released

      in Research/Science  172 upvotes 4 months ago
      Breezula shows promising hair growth results, with up to 539% increase in hair count compared to placebo, and regulatory submissions are planned in the US and EU. Users are cautiously optimistic, noting the potential for Breezula to replace finasteride by targeting DHT without systemic effects.